Search Results for "vol"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for vol. Results 131 to 140 of 1514 total matches.

FK 506 - An Investigational Immunosuppressant

   
The Medical Letter on Drugs and Therapeutics • Oct 04, 1991  (Issue 854)
). The Medical Letter, Vol. 33 (Issue 854) October 4, 1991, p. 94 Copyright  The Medical Letter UNAUTHORIZED ...
FK 506 (Fujisawa), an immunosuppressant similar in activity to cyclosporine (Sandimmune - Medical Letter 25:77, 1983), is currently under investigation in the USA, Europe, and Japan for prevention of organ transplant rejection.
Med Lett Drugs Ther. 1991 Oct 4;33(854):94 |  Show IntroductionHide Introduction

Drug Treatment of Cardiac Arrest

   
The Medical Letter on Drugs and Therapeutics • Mar 20, 1992  (Issue 866)
). The Medical Letter, Vol. 34 (Issue 866) March 20, 1992, p. 30 Copyright  The Medical Letter UNAUTHORIZED ...
Cardiac arrest may be due to tachyarrhythmias, bradyarrhythmias, or asystole. Without treatment, permanent damage to the cerebral cortex usually begins within five minutes and is complete in ten. After cardiopulmonary resuscitation (CPR) has been started and electrical defibrillation, when indicated, has been applied, drugs may help promote recovery.
Med Lett Drugs Ther. 1992 Mar 20;34(866):30 |  Show IntroductionHide Introduction

Topical Treatment for Bacterial Vaginosis

   
The Medical Letter on Drugs and Therapeutics • Nov 27, 1992  (Issue 884)
tolerated, for treatment of bacterial vaginosis. (continued on next page) The Medical Letter, Vol. 34 ...
A 0.75% vaginal gel formulation of metronidazole (MetroGel-Vaginal - Curatek) and a 2% vaginal cream formulation of clindamycin phosphate (Cleocin - Upjohn) were recently approved by the US Food and Drug Administration for treatment of bacterial vaginosis. Seven days' treatment with oral metronidazole, 500 mg b.i.d., has been the usual treatment for this condition, with oral clindamycin, 300 mg b.i.d., as an alternative (JL Thomason et al, Am J Obstet Gynecol, 165:1210, 1991).
Med Lett Drugs Ther. 1992 Nov 27;34(884):109-10 |  Show IntroductionHide Introduction

Paroxetine for Treatment of Depression

   
The Medical Letter on Drugs and Therapeutics • Mar 19, 1993  (Issue 892)
, the patient’s response to the starting dosage may not be The Medical Letter, Vol. 35 (Issue 892) March 19, 1993 ...
Paroxetine (Paxil - SmithKline Beecham), a new selective serotonin reuptake inhibitor (SSRI), is now available in the USA. Two other SSRIs, fluoxetine (Prozac - Medical Letter, 30:45, 1988; 32:83, 1990) and sertraline (Zoloft - Medical Letter, 34:47, 1992), were approved previously.
Med Lett Drugs Ther. 1993 Mar 19;35(892):24-5 |  Show IntroductionHide Introduction

Alpha-Galactosidase to Prevent Gas

   
The Medical Letter on Drugs and Therapeutics • Apr 02, 1993  (Issue 893)
Letter consultant reported The Medical Letter, Vol. 35 (Issue 893) April 2, 1993, pp. 29-30 Copyright ...
The enzyme alpha-galactosidase (Beano - AkPharma), derived from a mold and classified as a food, is sold without presecription in pharmacies and food stores. The manufacturer recommends taking the anzyme to decrease intestinal gas producted by eating the high-fiber diets now widely recommended in the USA.
Med Lett Drugs Ther. 1993 Apr 2;35(893):29-30 |  Show IntroductionHide Introduction

OncoScint for Detetion of Disseminated Colorectal and Ovarian Cancer

   
The Medical Letter on Drugs and Therapeutics • Jun 11, 1993  (Issue 898)
1993). The Medical Letter, Vol. 35 (Issue 898) June 11, 1993, pp. 52-53 Copyright  The Medical ...
Indium 111 In-satumomab pendetide (CYT-103, OncoScint CR/OV Kit - Cytogen), a new intravenous imaging agent, has been approved by the US Food and Drug Administration for detection of extrahepatic spread of colorectal and ovarian tumors.
Med Lett Drugs Ther. 1993 Jun 11;35(898):52-3 |  Show IntroductionHide Introduction

Shade UVAGuard - A Second Broad-Spectrum Sunscreen

   
The Medical Letter on Drugs and Therapeutics • Jun 11, 1993  (Issue 898)
to 4.8; the mean PPF for Shade UVAGuard The Medical Letter, Vol. 35 (Issue 898) June 11, 1993, pp. 53-54 ...
In 1989, Photoplex (Allergan Herbert), a combination of the dibenzoyl methane avobenzone (Parsol 1789) and the aminobenzoic acid (PABA) ester padimate O, was the first 'broad spectrum' sunscreen to become available in the USA (Medical Letter, 31:59, 1989). Now, Shade UVAGuard (Schering-Plough), a similar product, has been approved by the US Food and Drug Administration; it also contains avobenzone, plus the benzophenone oxybenzone and octyl methoxycinnamate.
Med Lett Drugs Ther. 1993 Jun 11;35(898):53-4 |  Show IntroductionHide Introduction

Drugs for Acute Spinal Cord Injury

   
The Medical Letter on Drugs and Therapeutics • Aug 06, 1993  (Issue 902)
degree of recovery; in terms of initially paralyzed muscle groups, treated The Medical Letter, Vol. 35 ...
The well-publicized recovery from paralysis of a professional football player has recently focused attention on the growing use of drugs to minimize the effects of spinal cord injury. Methylprednisolone sodium succinate (Solu-Medrol - Upjohn), commercially available in the USA for intravenous treatment of transplant rejection and various inflammatory and auto-immune disorders, and GM-1 ganglioside, commercially available in Italy (Sygen - Fidia) but not in the USA, are now widely used in patients with spinal cord injury.
Med Lett Drugs Ther. 1993 Aug 6;35(902):72-3 |  Show IntroductionHide Introduction

Radioactive Strontium-89 for Painful Bone Metastases

   
The Medical Letter on Drugs and Therapeutics • Oct 29, 1993  (Issue 908)
if necessary, but the risk of myelotoxicity is cumulative. The Medical Letter, Vol. 35 (Issue 908) October 29 ...
Strontium-89 chloride was recently approved for marketing by the US Food and Drug Administration. It is offered for relief of pain caused by metastatic bone lesions
Med Lett Drugs Ther. 1993 Oct 29;35(908):102 |  Show IntroductionHide Introduction

Home Testing of Cholesterol

   
The Medical Letter on Drugs and Therapeutics • Sep 30, 1994  (Issue 932)
the slide, and determining where the purple column ended. The Medical Letter, Vol. 36 (Issue 932) September ...
The new Advanced Care Cholesterol Test (Johnson & Johnson) now being advertised to the general public encourages patients to test their own serum cholesterol concentrations. Approved by the US Food and Drug Administration, this product is available in pharmacies without a prescription at a cost of about $20 for a single determination.
Med Lett Drugs Ther. 1994 Sep 30;36(932):85-6 |  Show IntroductionHide Introduction